Recent content from Joe Carlson
The company was helped by balanced growth across its business units.
Columbia Heights is an inner-ring suburban city of 20,158 people at the southernmost tip of Anoka County. The Heights has been a city for 96…
The company hopes that showing the device is effective in treating urethral strictures will lead to FDA approval.
Concern over organic sales growth sends the shares down in early trading
Medtronic CEO touts continual investment in innovation.
The $275M deal gives the device maker products to aid women's health.
Modern health care is pushing makers to think about reimbursement as part of the creation process.
Firm touts $10B market for its sleep apnea device.
Medtronic aims to lower hypertension with procedure, not drugs.
Amplifon will move its U.S. offices from Plymouth to the Fifth Street Towers.
Dr. Laura Mauri will start to transition into the new job in June, and will fully assume the role on Sept. 1.
Ferring says it plans few changes at flourishing Roseville company
Respiratory medical device maker Vyaire Medical plans to close its plant in Plymouth by June 30, eliminating approximately 50 jobs, according to state officials.
Researchers found that a surprising number of the earliest studies on treatments for chronic conditions presented exaggerated results.
Dead patient's mom wins rare appeal in suit over Medtronic's drug pump.
The system creates cardiac maps that can help guide procedures.
Regulators say Monteris hasn't sufficiently addressed safety concerns raised last year.
Potential $406M deal includes NxThera's promising and novel prostate treatment system, Rezum.
Inspector general's report said $4.4M should have been sent to Medicare.
FDA said products could contain undeclared latex, resulting in an unintended allergic reaction.
The Minnetonka medical device maker will keep its ties to state as part of Canada's Laborie Medical Technology.
HeartMate 3 performed better in clinical test than Abbott's older device.
Companies say patients not in danger while pledging vigilance.
Device was invented by St. Jude Medical, which is now part of Abbott Labs.
Company admits to slow reaction to device flaw but says patients weren't at risk.
A Minnesota company has developed a souped-up swim cap that offers competitive swimmers protection in a collision.
Unique collaboration with Pa. health network could improve care, reduce costs.
Investors sent shares of Surmodics up nearly 10 percent on news of the pact.
The Twin Cities area is emerging as a major player in what could become a multibillion dollar industry.
Glucose monitor can be worn on the upper arm.
A test program has yielded promising results at Ebenezer Care Center.
FTC says bulk discounts denied to buying groups for small dental firms; Patterson says the suit is "meritless."
The recall affects 33,000 cases that contain blankets with a design that makes them susceptible to an airflow blockage.
Roseville-based Rebiotix says new measurements can help against "C. diff."
The U.S. attorney's office accuses the Bloomington firm of providing expensive hunting trips and other payments to doctors who might use its products.
Plaintiffs allege Medtronic paid doctors to conceal problems; company vows to fight case.
The company said all divisions posted sales growth in the last quarter.
During a tumultuous childhood in western Minnesota, Troy Quenemoen immersed himself in the world of comic books, where obstacles are always overcome and individual acts…
Rhonda Robb will be COO at medical device maker in New Brighton.
Removing clots up to 16 hours after the stroke can be effective, researchers have found.
Sales growth generated by the Little Canada device maker carried through 2017.
Owners of the Shoreview medical device company pay $7.6M to settle case.
The device is used to treat vessels that are blocked with calcified plaque.
Increased demand for urology treatment is raising expectations at the device firm.
Lawsuit claimed devicemaker defrauded the federal government.
The companies announced the data as an industry conference gathered this week in Las Vegas.
Judge cites lack of evidence showing investors were deliberately misled.
Unless Congress acts, the ACA measure will return this month after a reprieve.
Problems with earlier version had led to restrictions by FDA.
Preliminary revenue was up about 10 percent from last year.
Ruling on 3M product doesn't affect some 4,000 similar suits pending in federal court.
Litigant said shareholders were harmed financially by Medtronic's actions.
Medical device firm will study new treatment option for type 2 diabetes.
Minneapolis-based Bio-Techne Corp., which makes biological supplies and machines used in research by the pharmaceutical industry, has acquired a small firm in Georgia called Atlanta…
Approval clears way for sale of pacemaker made by company's China-based partner.
Minnetonka-based firm touts $58.5 million boost.
The Vercise system aims to minimize negative side effects of DBS therapy
John Bottko doesn’t want to have a heart defibrillator implanted in his chest — he doesn’t want the pain of surgery, and he definitely doesn’t…
Thousands of plaintiffs are suing 3M as part of a federal Multi District Litigation centralized in Minnesota.
The device maker continues to deny allegations made by states, which include using misleading data to drive Infuse sales.
UnitedHealth Group, Aetna and CVS Health attempt to revamp who does what in delivering health care.
It's unclear how the deal would affect the 280 workers employed by the maker of products to treat sinus problems.
The deal includes medical staff of 2,000 and further blurs insurance, provider line.
Along with tracking a wearer's workout, company hopes to show its watch can effectively detect atrial fibrillation.
Company sees no concern for its own Aetna venture.
At issue is whether CorVascular should pay defense expenses for the former employees it is suing.
Device maker said it is unclear when it will submit troubled system for U.S. approval.
UnitedHealth Group issued financial guidance late Monday that included a projected range for 2018 earnings that dipped below analysts expectations. Its shares fell about 1 percent in after-hours trading.
With $1.4 billion in question, feud may have implications for industry.
Analysts believe the company can meet growth targets despite recent production headaches.
Critics say cheaper stents have not added up to savings for patients.
Minnesota-run company has emerged as a major winner in the $1.7 billion U.S. market.
Two U.S. senators are urging the agency that controls Medicare to support putting the full serial numbers for medical devices into insurance-claims forms to better track how poorly performing devices affect federal spending and patient health.
Medtronic lost as much as $65 million in revenue in the weeks following Hurricane Maria, which incapacitated the medical device maker’s four factories in Puerto…
June Haddow had met someone special in Marseille. The couple had been cooking together, making art, going on lots of walks, spending time as young…
More from Star Tribune